Info
ASPC manual of preventive cardiology / / editors, Nathan D. Wong, Ezra A. Amsterdam, and Roger S. Blumenthal
| ASPC manual of preventive cardiology / / editors, Nathan D. Wong, Ezra A. Amsterdam, and Roger S. Blumenthal |
| Pubbl/distr/stampa | New York : , : demosMEDICAL, , 2015 |
| Descrizione fisica | 1 online resource (295 p.) |
| Disciplina | 616.1/05 |
| Soggetto topico | Cardiovascular system - Diseases - Prevention |
| Soggetto genere / forma | Electronic books. |
| ISBN | 1-61705-141-1 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cover; Title; Copyright; Contents; Contributors; Foreword; Preface; Acknowledgments; Share ASPC Manual of Preventive Cardiology; Chapter 1: National Burden of Cardiovascular Disease and Associated Risk Factors; Cardiovascular Disease; Mortality and Morbidity Attributable to CVD; Prevalence and Control of Cardiovascular Risk Factors; Subclinical Atherosclerosis; Ankle-Brachial Index; Economic Costs of Cardiovascular Disease; Summary; Acknowledgments; References; Chapter 2: Cardiovascular Risk Assessment; Rationale for Contemporary CV Risk Prediction
Relative Risk Versus Absolute Cardiovascular RiskTreatment Benefit Depends on Absolute Risk Rather Than Relative Risk; Multiple, Online Risk Prediction Tools for CVD are Widely Available; Current Guideline Recommendations; Current Clinical Practice Guidelines Suggest That the Indication and Intensity of Treatment Should Be Proportional to the Absolute Risk for CVD; Novel Developments in Global CVD Risk: Considering Alternative CVD Outcomes; Novel Developments in Global CVD Risk: Considering Alternative Risk Factors; Novel Serum Markers; Novel Imaging Markers; Other Risk Markers Novel Developments in Global CVD Risk: Considering Long-Term or Lifetime RiskConclusion; References; Chapter 3: The New American Prevention Guidelines: Aligning the Guidelines for Atherosclerotic Cardiovascular Risk Reduction With the Evidence; A New Approach; Major Themes; What You Need to Know; A. Heart Healthy Nutrition and Physical Activity Behaviors; B. Recommendations from the Risk Assessment Workgroup With Those Reflecting Expert Opinion Highlighted in Italics; C. Graded Recommendations for Statin Treatment to Reduce ASCVD Risk Footnotes to this Section (from the Cholesterol Guideline Report)Statin Safety Recommendations; Footnotes to this Section (from the Cholesterol Guideline Report); Monitoring Statin Therapy; Optimizing Statin Therapy; Insufficient Response to Statin Therapy; Footnotes to this Section (from the Cholesterol Guideline Report); Conclusions; References; Chapter 4: Management of High Blood Pressure; Epidemiology of Hypertension; Definition and Classification of Hypertension; Initial Evaluation of the Patient; Thresholds for Initiating Therapy; Lifestyle Modifications; Initial Drug Therapy Goal Blood Pressure for "Uncomplicated" Hypertensive PatientsGoal Blood Pressure for Hypertensive Patients with Other High-Risk Conditions; Other Issues; References; Chapter 5: Smoking and Passive Smoking; Smoking and Cardiovascular Disease; Secondhand Smoke; Trends in Cigarette Smoking; Prevention and Reduction of Tobacco Use Among Youth; Prevention and Cessation Programs for Adults; Cessation Strategies for Individuals; Behavioral Treatments; Pharmacologic Interventions; Clinical Approaches; Conclusions; References; Chapter 6: Metabolic Syndrome; History, Prevalence, and Epidemiology Definition |
| Record Nr. | UNINA-9910463373803321 |
| New York : , : demosMEDICAL, , 2015 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
ASPC manual of preventive cardiology / / editors, Nathan D. Wong, Ezra A. Amsterdam, and Roger S. Blumenthal
| ASPC manual of preventive cardiology / / editors, Nathan D. Wong, Ezra A. Amsterdam, and Roger S. Blumenthal |
| Pubbl/distr/stampa | New York : , : demosMEDICAL, , 2015 |
| Descrizione fisica | 1 online resource (295 p.) |
| Disciplina | 616.1/05 |
| Soggetto topico | Cardiovascular system - Diseases - Prevention |
| ISBN | 1-61705-141-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cover; Title; Copyright; Contents; Contributors; Foreword; Preface; Acknowledgments; Share ASPC Manual of Preventive Cardiology; Chapter 1: National Burden of Cardiovascular Disease and Associated Risk Factors; Cardiovascular Disease; Mortality and Morbidity Attributable to CVD; Prevalence and Control of Cardiovascular Risk Factors; Subclinical Atherosclerosis; Ankle-Brachial Index; Economic Costs of Cardiovascular Disease; Summary; Acknowledgments; References; Chapter 2: Cardiovascular Risk Assessment; Rationale for Contemporary CV Risk Prediction
Relative Risk Versus Absolute Cardiovascular RiskTreatment Benefit Depends on Absolute Risk Rather Than Relative Risk; Multiple, Online Risk Prediction Tools for CVD are Widely Available; Current Guideline Recommendations; Current Clinical Practice Guidelines Suggest That the Indication and Intensity of Treatment Should Be Proportional to the Absolute Risk for CVD; Novel Developments in Global CVD Risk: Considering Alternative CVD Outcomes; Novel Developments in Global CVD Risk: Considering Alternative Risk Factors; Novel Serum Markers; Novel Imaging Markers; Other Risk Markers Novel Developments in Global CVD Risk: Considering Long-Term or Lifetime RiskConclusion; References; Chapter 3: The New American Prevention Guidelines: Aligning the Guidelines for Atherosclerotic Cardiovascular Risk Reduction With the Evidence; A New Approach; Major Themes; What You Need to Know; A. Heart Healthy Nutrition and Physical Activity Behaviors; B. Recommendations from the Risk Assessment Workgroup With Those Reflecting Expert Opinion Highlighted in Italics; C. Graded Recommendations for Statin Treatment to Reduce ASCVD Risk Footnotes to this Section (from the Cholesterol Guideline Report)Statin Safety Recommendations; Footnotes to this Section (from the Cholesterol Guideline Report); Monitoring Statin Therapy; Optimizing Statin Therapy; Insufficient Response to Statin Therapy; Footnotes to this Section (from the Cholesterol Guideline Report); Conclusions; References; Chapter 4: Management of High Blood Pressure; Epidemiology of Hypertension; Definition and Classification of Hypertension; Initial Evaluation of the Patient; Thresholds for Initiating Therapy; Lifestyle Modifications; Initial Drug Therapy Goal Blood Pressure for "Uncomplicated" Hypertensive PatientsGoal Blood Pressure for Hypertensive Patients with Other High-Risk Conditions; Other Issues; References; Chapter 5: Smoking and Passive Smoking; Smoking and Cardiovascular Disease; Secondhand Smoke; Trends in Cigarette Smoking; Prevention and Reduction of Tobacco Use Among Youth; Prevention and Cessation Programs for Adults; Cessation Strategies for Individuals; Behavioral Treatments; Pharmacologic Interventions; Clinical Approaches; Conclusions; References; Chapter 6: Metabolic Syndrome; History, Prevalence, and Epidemiology Definition |
| Record Nr. | UNINA-9910787804503321 |
| New York : , : demosMEDICAL, , 2015 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
ASPC manual of preventive cardiology / / editors, Nathan D. Wong, Ezra A. Amsterdam, and Roger S. Blumenthal
| ASPC manual of preventive cardiology / / editors, Nathan D. Wong, Ezra A. Amsterdam, and Roger S. Blumenthal |
| Pubbl/distr/stampa | New York : , : demosMEDICAL, , 2015 |
| Descrizione fisica | 1 online resource (295 p.) |
| Disciplina | 616.1/05 |
| Soggetto topico | Cardiovascular system - Diseases - Prevention |
| ISBN | 1-61705-141-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cover; Title; Copyright; Contents; Contributors; Foreword; Preface; Acknowledgments; Share ASPC Manual of Preventive Cardiology; Chapter 1: National Burden of Cardiovascular Disease and Associated Risk Factors; Cardiovascular Disease; Mortality and Morbidity Attributable to CVD; Prevalence and Control of Cardiovascular Risk Factors; Subclinical Atherosclerosis; Ankle-Brachial Index; Economic Costs of Cardiovascular Disease; Summary; Acknowledgments; References; Chapter 2: Cardiovascular Risk Assessment; Rationale for Contemporary CV Risk Prediction
Relative Risk Versus Absolute Cardiovascular RiskTreatment Benefit Depends on Absolute Risk Rather Than Relative Risk; Multiple, Online Risk Prediction Tools for CVD are Widely Available; Current Guideline Recommendations; Current Clinical Practice Guidelines Suggest That the Indication and Intensity of Treatment Should Be Proportional to the Absolute Risk for CVD; Novel Developments in Global CVD Risk: Considering Alternative CVD Outcomes; Novel Developments in Global CVD Risk: Considering Alternative Risk Factors; Novel Serum Markers; Novel Imaging Markers; Other Risk Markers Novel Developments in Global CVD Risk: Considering Long-Term or Lifetime RiskConclusion; References; Chapter 3: The New American Prevention Guidelines: Aligning the Guidelines for Atherosclerotic Cardiovascular Risk Reduction With the Evidence; A New Approach; Major Themes; What You Need to Know; A. Heart Healthy Nutrition and Physical Activity Behaviors; B. Recommendations from the Risk Assessment Workgroup With Those Reflecting Expert Opinion Highlighted in Italics; C. Graded Recommendations for Statin Treatment to Reduce ASCVD Risk Footnotes to this Section (from the Cholesterol Guideline Report)Statin Safety Recommendations; Footnotes to this Section (from the Cholesterol Guideline Report); Monitoring Statin Therapy; Optimizing Statin Therapy; Insufficient Response to Statin Therapy; Footnotes to this Section (from the Cholesterol Guideline Report); Conclusions; References; Chapter 4: Management of High Blood Pressure; Epidemiology of Hypertension; Definition and Classification of Hypertension; Initial Evaluation of the Patient; Thresholds for Initiating Therapy; Lifestyle Modifications; Initial Drug Therapy Goal Blood Pressure for "Uncomplicated" Hypertensive PatientsGoal Blood Pressure for Hypertensive Patients with Other High-Risk Conditions; Other Issues; References; Chapter 5: Smoking and Passive Smoking; Smoking and Cardiovascular Disease; Secondhand Smoke; Trends in Cigarette Smoking; Prevention and Reduction of Tobacco Use Among Youth; Prevention and Cessation Programs for Adults; Cessation Strategies for Individuals; Behavioral Treatments; Pharmacologic Interventions; Clinical Approaches; Conclusions; References; Chapter 6: Metabolic Syndrome; History, Prevalence, and Epidemiology Definition |
| Record Nr. | UNINA-9910821507203321 |
| New York : , : demosMEDICAL, , 2015 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Cardiovascular genetics and genomics in clinical practice / / editors, Sanjiv J. Shah, Donna K. Arnett
| Cardiovascular genetics and genomics in clinical practice / / editors, Sanjiv J. Shah, Donna K. Arnett |
| Pubbl/distr/stampa | New York : , : demosMEDICAL, , 2015 |
| Descrizione fisica | 1 online resource (326 p.) |
| Disciplina | 616.1/2042 |
| Soggetto topico | Heart - Diseases - Genetic aspects |
| Soggetto genere / forma | Electronic books. |
| ISBN | 1-61705-178-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cover; Title; Copyright; Contents; Contributors; Preface; References; Video Captions; Share Cardiovascular Genetics and Genomics in Clinical Practice; Part I: Genetics and Genomics: The Basics; Chapter 1: Mendelian Genetics; Take Home Points; Mendel's Laws; Modes of Inheritance; Methods Used to Determine Modes of Inheritance; Clinical Utility of Genetic Information; Glossary; References; Chapter 2: Genetics of Complex Traits; Take Home Points; Quantitative Traits; Familial Aggregation; Measuring Familial Aggregation; Concordance Versus Discordance; Allele Sharing; Twin Studies
Concordance of MZ Versus DZ TwinsTwins Reared Apart; Limitations of Twin Studies; Heritability; Conclusions; References; Chapter 3: Genome-Wide Association Studies; Take Home Points; Why do we Need GWAS?; Genetic Basis of GWAS; Simple GWAS; Beyond GWAS Basics: Challenges and Limitations; Limitations of GWAS; Using GWAS Results; GWAS Success in Cardiovascular Disease; Summary; Glossary; References; Chapter 4: Bioinformatics; Take Home Points; Following Up on Linkage Analyses; Following Up on Genome-Wide Association Studies; Obtaining Information on Candidate Genes Characterizing DNA Variants Found within GenesReferences; Chapter 5: Epigenetics; Take Home Points; DNA Methylation; Histone Modifications; Challenges and Opportunities for Human CVD Epigenetic Studies; References; Chapter 6: MicroRNAs; Take Home Points; MicroRNA Structure and Function; MicroRNA and Cardiac Function; MicroRNA as Biomarkers; MicroRNA Therapeutics; Conclusions; References; Chapter 7: Gene Expression; Take Home Points; Microarray Technology; Quality Control; Data Normalization; Data Analysis; Ontology and Pathway Analysis; Validation and Meta-Analysis; Conclusions; References Chapter 8: Whole-Exome and Whole-Genome SequencingTake Home Points; Overview of Exome Chip, WES, and WGS Technologies; Available Strategies for the Conduct of WES Studies; Application of WES to Cardiovascular Disease; Next-Generation Sequencing Technologies for Clinical Diagnostics; Future Directions; Conclusions; References; Chapter 9: Gene-Environment Interactions; Take Home Points; Defining Interactions; Investigating Interactions: Study Design; Investigating Interactions: Statistical Power; Gene-Environment Interactions in Cardiovascular Disease The Promise and Challenges of Gene-Environment Interaction ResearchSummary; References; Chapter 10: Genetic Counseling; Take Home Points; Definition of Genetic Counseling; The Power of the Pedigree and Family Health History; Risk Assessment Beyond Basic Mendelian Principle; Psychosocial Counseling; Genetic Counselors in Cardiovascular Practice; Cardiovascular Genetic Testing; Partners in Practice; Conclusions; References; Part II: Genetics of Cardiovascular Disorders/Traits; Chapter 11: Blood Pressure Genomics; Take Home Points Case Study: Severe Monogenic Hypertension-An Application of Whole-Exome Sequencing |
| Record Nr. | UNINA-9910463374403321 |
| New York : , : demosMEDICAL, , 2015 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Cardiovascular genetics and genomics in clinical practice / / editors, Sanjiv J. Shah, Donna K. Arnett
| Cardiovascular genetics and genomics in clinical practice / / editors, Sanjiv J. Shah, Donna K. Arnett |
| Pubbl/distr/stampa | New York : , : demosMEDICAL, , 2015 |
| Descrizione fisica | 1 online resource (326 p.) |
| Disciplina | 616.1/2042 |
| Soggetto topico | Heart - Diseases - Genetic aspects |
| ISBN | 1-61705-178-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cover; Title; Copyright; Contents; Contributors; Preface; References; Video Captions; Share Cardiovascular Genetics and Genomics in Clinical Practice; Part I: Genetics and Genomics: The Basics; Chapter 1: Mendelian Genetics; Take Home Points; Mendel's Laws; Modes of Inheritance; Methods Used to Determine Modes of Inheritance; Clinical Utility of Genetic Information; Glossary; References; Chapter 2: Genetics of Complex Traits; Take Home Points; Quantitative Traits; Familial Aggregation; Measuring Familial Aggregation; Concordance Versus Discordance; Allele Sharing; Twin Studies
Concordance of MZ Versus DZ TwinsTwins Reared Apart; Limitations of Twin Studies; Heritability; Conclusions; References; Chapter 3: Genome-Wide Association Studies; Take Home Points; Why do we Need GWAS?; Genetic Basis of GWAS; Simple GWAS; Beyond GWAS Basics: Challenges and Limitations; Limitations of GWAS; Using GWAS Results; GWAS Success in Cardiovascular Disease; Summary; Glossary; References; Chapter 4: Bioinformatics; Take Home Points; Following Up on Linkage Analyses; Following Up on Genome-Wide Association Studies; Obtaining Information on Candidate Genes Characterizing DNA Variants Found within GenesReferences; Chapter 5: Epigenetics; Take Home Points; DNA Methylation; Histone Modifications; Challenges and Opportunities for Human CVD Epigenetic Studies; References; Chapter 6: MicroRNAs; Take Home Points; MicroRNA Structure and Function; MicroRNA and Cardiac Function; MicroRNA as Biomarkers; MicroRNA Therapeutics; Conclusions; References; Chapter 7: Gene Expression; Take Home Points; Microarray Technology; Quality Control; Data Normalization; Data Analysis; Ontology and Pathway Analysis; Validation and Meta-Analysis; Conclusions; References Chapter 8: Whole-Exome and Whole-Genome SequencingTake Home Points; Overview of Exome Chip, WES, and WGS Technologies; Available Strategies for the Conduct of WES Studies; Application of WES to Cardiovascular Disease; Next-Generation Sequencing Technologies for Clinical Diagnostics; Future Directions; Conclusions; References; Chapter 9: Gene-Environment Interactions; Take Home Points; Defining Interactions; Investigating Interactions: Study Design; Investigating Interactions: Statistical Power; Gene-Environment Interactions in Cardiovascular Disease The Promise and Challenges of Gene-Environment Interaction ResearchSummary; References; Chapter 10: Genetic Counseling; Take Home Points; Definition of Genetic Counseling; The Power of the Pedigree and Family Health History; Risk Assessment Beyond Basic Mendelian Principle; Psychosocial Counseling; Genetic Counselors in Cardiovascular Practice; Cardiovascular Genetic Testing; Partners in Practice; Conclusions; References; Part II: Genetics of Cardiovascular Disorders/Traits; Chapter 11: Blood Pressure Genomics; Take Home Points Case Study: Severe Monogenic Hypertension-An Application of Whole-Exome Sequencing |
| Record Nr. | UNINA-9910787805003321 |
| New York : , : demosMEDICAL, , 2015 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Cardiovascular genetics and genomics in clinical practice / / editors, Sanjiv J. Shah, Donna K. Arnett
| Cardiovascular genetics and genomics in clinical practice / / editors, Sanjiv J. Shah, Donna K. Arnett |
| Pubbl/distr/stampa | New York : , : demosMEDICAL, , 2015 |
| Descrizione fisica | 1 online resource (326 p.) |
| Disciplina | 616.1/2042 |
| Soggetto topico | Heart - Diseases - Genetic aspects |
| ISBN | 1-61705-178-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cover; Title; Copyright; Contents; Contributors; Preface; References; Video Captions; Share Cardiovascular Genetics and Genomics in Clinical Practice; Part I: Genetics and Genomics: The Basics; Chapter 1: Mendelian Genetics; Take Home Points; Mendel's Laws; Modes of Inheritance; Methods Used to Determine Modes of Inheritance; Clinical Utility of Genetic Information; Glossary; References; Chapter 2: Genetics of Complex Traits; Take Home Points; Quantitative Traits; Familial Aggregation; Measuring Familial Aggregation; Concordance Versus Discordance; Allele Sharing; Twin Studies
Concordance of MZ Versus DZ TwinsTwins Reared Apart; Limitations of Twin Studies; Heritability; Conclusions; References; Chapter 3: Genome-Wide Association Studies; Take Home Points; Why do we Need GWAS?; Genetic Basis of GWAS; Simple GWAS; Beyond GWAS Basics: Challenges and Limitations; Limitations of GWAS; Using GWAS Results; GWAS Success in Cardiovascular Disease; Summary; Glossary; References; Chapter 4: Bioinformatics; Take Home Points; Following Up on Linkage Analyses; Following Up on Genome-Wide Association Studies; Obtaining Information on Candidate Genes Characterizing DNA Variants Found within GenesReferences; Chapter 5: Epigenetics; Take Home Points; DNA Methylation; Histone Modifications; Challenges and Opportunities for Human CVD Epigenetic Studies; References; Chapter 6: MicroRNAs; Take Home Points; MicroRNA Structure and Function; MicroRNA and Cardiac Function; MicroRNA as Biomarkers; MicroRNA Therapeutics; Conclusions; References; Chapter 7: Gene Expression; Take Home Points; Microarray Technology; Quality Control; Data Normalization; Data Analysis; Ontology and Pathway Analysis; Validation and Meta-Analysis; Conclusions; References Chapter 8: Whole-Exome and Whole-Genome SequencingTake Home Points; Overview of Exome Chip, WES, and WGS Technologies; Available Strategies for the Conduct of WES Studies; Application of WES to Cardiovascular Disease; Next-Generation Sequencing Technologies for Clinical Diagnostics; Future Directions; Conclusions; References; Chapter 9: Gene-Environment Interactions; Take Home Points; Defining Interactions; Investigating Interactions: Study Design; Investigating Interactions: Statistical Power; Gene-Environment Interactions in Cardiovascular Disease The Promise and Challenges of Gene-Environment Interaction ResearchSummary; References; Chapter 10: Genetic Counseling; Take Home Points; Definition of Genetic Counseling; The Power of the Pedigree and Family Health History; Risk Assessment Beyond Basic Mendelian Principle; Psychosocial Counseling; Genetic Counselors in Cardiovascular Practice; Cardiovascular Genetic Testing; Partners in Practice; Conclusions; References; Part II: Genetics of Cardiovascular Disorders/Traits; Chapter 11: Blood Pressure Genomics; Take Home Points Case Study: Severe Monogenic Hypertension-An Application of Whole-Exome Sequencing |
| Record Nr. | UNINA-9910815659203321 |
| New York : , : demosMEDICAL, , 2015 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Medical complications in physical medicine and rehabilitation / / editors, Diana D. Cardenas, Thomas M. Hooton
| Medical complications in physical medicine and rehabilitation / / editors, Diana D. Cardenas, Thomas M. Hooton |
| Pubbl/distr/stampa | New York : , : demosMEDICAL, , 2015 |
| Descrizione fisica | 1 online resource (ix, 294 pages) : illustrations |
| Disciplina | 617.1/03 |
| Soggetto topico |
Medical rehabilitation
Wounds and injuries |
| Soggetto genere / forma | Electronic books. |
| ISBN | 1-61705-082-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cover; Title; Copyright; Contents; Contributors; Preface; Part I: Medical Complications by Rehabilitation Diagnostic Categories; Chapter 1: Musculoskeletal Disorders; Total Hip Arthroplasty; Total Knee Arthroplasty; Rehabilitation of TJA; Complications During Acute Rehabilitation; Late Complications; References; Chapter 2: Spinal Cord Injury; Epidemiology of Traumatic Spinal Cord Injury; Early and Late Medical Complications; Musculoskeletal Complications; Pulmonary Complications; Cardiovascular Complications; Skin Complications; Posttraumatic Syringomyelia; Endocrine Complications; References
Chapter 3: Multiple Trauma and BurnsMultiple Trauma; Burns; Summary; References; Chapter 4: Stroke; Maintenance of Homeostasis; Complications of Immobility; Falls and Fractures/Trauma; Poststroke Pain Syndromes; Depression and Pseudobulbar Affect; Secondary Stroke Prevention; Summary; References; Chapter 5: Traumatic Brain Injury; Epidemiology of Traumatic Brain Injury; Etiology of TBI; Agitation; Posttraumatic Seizures; Posttraumatic Hydrocephalus; Autonomic Storming; Metabolic and Endocrine Disruption Following TBI; Upper Motor Neuron Syndrome; Acute and Chronic Pain Respiratory ComplicationsDysphagia; References; Chapter 6: Neurological and Rheumatological Disorders; Neurological Disorders; Rheumatologic Disorders; References; Chapter 7: Cancer Rehabilitation; Cancer; Selective Issues in Cancer Rehabilitation; Conclusion; References; Chapter 8: Amputations; Medical Complications in Patients with Amputations; References; Part II: Specific Medical Complications; Chapter 9: Fever; Background; Definitions; Terms Used to Describe Severe Infections; Etiology of Fever; Infectious Causes of Fever; Noninfectious Causes of Fever; Evaluation of the Febrile Patient Special Considerations Regarding Microbiologic CulturesInterpretation of Microbiologic Cultures; Management; Summary; References; Chapter 10: Acute Chest Pain; History and Physical Examination; Acute Coronary Syndromes; Electrocardiogram (ECG); Chest Radiography; Laboratory Tests; A Stepwise Approach to Evaluation of Acute Chest Pain; References; Chapter 11: Common Laboratory Abnormalities; Hypoglycemia and Hyperglycemia; Hypokalemia and Hyperkalemia; Hyponatremia and Hypernatremia; Hypocalcemia and Hypercalcemia; Azotemia; Abnormal Liver Function Tests; Bibliography Chapter 12: Urinary Tract InfectionDefinitions; Epidemiology; Microbiology; Diagnosis; Prevention; Management; Funguria; Summary; References; Chapter 13: Pulmonary Disorders; Obstructive Lung Disease (Asthma and Chronic Obstructive Pulmonary Disease); Interstitial Lung Disease; Neuromuscular Disease; Post-ICU Care; Pulmonary Complications in Rehabilitation; Pneumonia; References; Chapter 14: Osteomyelitis; Classification; Diagnosis; Microbiology; Treatment; Summary; References; Chapter 15: Clostridium Difficile Colitis; Antibiotic-AssociatedDiarrhea Toxigenic Versus Nontoxigenic Clostridium Difficile |
| Record Nr. | UNINA-9910464778103321 |
| New York : , : demosMEDICAL, , 2015 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Medical complications in physical medicine and rehabilitation / / editors, Diana D. Cardenas, Thomas M. Hooton
| Medical complications in physical medicine and rehabilitation / / editors, Diana D. Cardenas, Thomas M. Hooton |
| Pubbl/distr/stampa | New York : , : demosMEDICAL, , 2015 |
| Descrizione fisica | 1 online resource (ix, 294 pages) : illustrations |
| Disciplina | 617.1/03 |
| Soggetto topico |
Medical rehabilitation
Wounds and injuries |
| ISBN | 1-61705-082-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cover; Title; Copyright; Contents; Contributors; Preface; Part I: Medical Complications by Rehabilitation Diagnostic Categories; Chapter 1: Musculoskeletal Disorders; Total Hip Arthroplasty; Total Knee Arthroplasty; Rehabilitation of TJA; Complications During Acute Rehabilitation; Late Complications; References; Chapter 2: Spinal Cord Injury; Epidemiology of Traumatic Spinal Cord Injury; Early and Late Medical Complications; Musculoskeletal Complications; Pulmonary Complications; Cardiovascular Complications; Skin Complications; Posttraumatic Syringomyelia; Endocrine Complications; References
Chapter 3: Multiple Trauma and BurnsMultiple Trauma; Burns; Summary; References; Chapter 4: Stroke; Maintenance of Homeostasis; Complications of Immobility; Falls and Fractures/Trauma; Poststroke Pain Syndromes; Depression and Pseudobulbar Affect; Secondary Stroke Prevention; Summary; References; Chapter 5: Traumatic Brain Injury; Epidemiology of Traumatic Brain Injury; Etiology of TBI; Agitation; Posttraumatic Seizures; Posttraumatic Hydrocephalus; Autonomic Storming; Metabolic and Endocrine Disruption Following TBI; Upper Motor Neuron Syndrome; Acute and Chronic Pain Respiratory ComplicationsDysphagia; References; Chapter 6: Neurological and Rheumatological Disorders; Neurological Disorders; Rheumatologic Disorders; References; Chapter 7: Cancer Rehabilitation; Cancer; Selective Issues in Cancer Rehabilitation; Conclusion; References; Chapter 8: Amputations; Medical Complications in Patients with Amputations; References; Part II: Specific Medical Complications; Chapter 9: Fever; Background; Definitions; Terms Used to Describe Severe Infections; Etiology of Fever; Infectious Causes of Fever; Noninfectious Causes of Fever; Evaluation of the Febrile Patient Special Considerations Regarding Microbiologic CulturesInterpretation of Microbiologic Cultures; Management; Summary; References; Chapter 10: Acute Chest Pain; History and Physical Examination; Acute Coronary Syndromes; Electrocardiogram (ECG); Chest Radiography; Laboratory Tests; A Stepwise Approach to Evaluation of Acute Chest Pain; References; Chapter 11: Common Laboratory Abnormalities; Hypoglycemia and Hyperglycemia; Hypokalemia and Hyperkalemia; Hyponatremia and Hypernatremia; Hypocalcemia and Hypercalcemia; Azotemia; Abnormal Liver Function Tests; Bibliography Chapter 12: Urinary Tract InfectionDefinitions; Epidemiology; Microbiology; Diagnosis; Prevention; Management; Funguria; Summary; References; Chapter 13: Pulmonary Disorders; Obstructive Lung Disease (Asthma and Chronic Obstructive Pulmonary Disease); Interstitial Lung Disease; Neuromuscular Disease; Post-ICU Care; Pulmonary Complications in Rehabilitation; Pneumonia; References; Chapter 14: Osteomyelitis; Classification; Diagnosis; Microbiology; Treatment; Summary; References; Chapter 15: Clostridium Difficile Colitis; Antibiotic-AssociatedDiarrhea Toxigenic Versus Nontoxigenic Clostridium Difficile |
| Record Nr. | UNINA-9910786550803321 |
| New York : , : demosMEDICAL, , 2015 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Medical complications in physical medicine and rehabilitation / / editors, Diana D. Cardenas, Thomas M. Hooton
| Medical complications in physical medicine and rehabilitation / / editors, Diana D. Cardenas, Thomas M. Hooton |
| Pubbl/distr/stampa | New York : , : demosMEDICAL, , 2015 |
| Descrizione fisica | 1 online resource (ix, 294 pages) : illustrations |
| Disciplina | 617.1/03 |
| Soggetto topico |
Medical rehabilitation
Wounds and injuries |
| ISBN | 1-61705-082-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cover; Title; Copyright; Contents; Contributors; Preface; Part I: Medical Complications by Rehabilitation Diagnostic Categories; Chapter 1: Musculoskeletal Disorders; Total Hip Arthroplasty; Total Knee Arthroplasty; Rehabilitation of TJA; Complications During Acute Rehabilitation; Late Complications; References; Chapter 2: Spinal Cord Injury; Epidemiology of Traumatic Spinal Cord Injury; Early and Late Medical Complications; Musculoskeletal Complications; Pulmonary Complications; Cardiovascular Complications; Skin Complications; Posttraumatic Syringomyelia; Endocrine Complications; References
Chapter 3: Multiple Trauma and BurnsMultiple Trauma; Burns; Summary; References; Chapter 4: Stroke; Maintenance of Homeostasis; Complications of Immobility; Falls and Fractures/Trauma; Poststroke Pain Syndromes; Depression and Pseudobulbar Affect; Secondary Stroke Prevention; Summary; References; Chapter 5: Traumatic Brain Injury; Epidemiology of Traumatic Brain Injury; Etiology of TBI; Agitation; Posttraumatic Seizures; Posttraumatic Hydrocephalus; Autonomic Storming; Metabolic and Endocrine Disruption Following TBI; Upper Motor Neuron Syndrome; Acute and Chronic Pain Respiratory ComplicationsDysphagia; References; Chapter 6: Neurological and Rheumatological Disorders; Neurological Disorders; Rheumatologic Disorders; References; Chapter 7: Cancer Rehabilitation; Cancer; Selective Issues in Cancer Rehabilitation; Conclusion; References; Chapter 8: Amputations; Medical Complications in Patients with Amputations; References; Part II: Specific Medical Complications; Chapter 9: Fever; Background; Definitions; Terms Used to Describe Severe Infections; Etiology of Fever; Infectious Causes of Fever; Noninfectious Causes of Fever; Evaluation of the Febrile Patient Special Considerations Regarding Microbiologic CulturesInterpretation of Microbiologic Cultures; Management; Summary; References; Chapter 10: Acute Chest Pain; History and Physical Examination; Acute Coronary Syndromes; Electrocardiogram (ECG); Chest Radiography; Laboratory Tests; A Stepwise Approach to Evaluation of Acute Chest Pain; References; Chapter 11: Common Laboratory Abnormalities; Hypoglycemia and Hyperglycemia; Hypokalemia and Hyperkalemia; Hyponatremia and Hypernatremia; Hypocalcemia and Hypercalcemia; Azotemia; Abnormal Liver Function Tests; Bibliography Chapter 12: Urinary Tract InfectionDefinitions; Epidemiology; Microbiology; Diagnosis; Prevention; Management; Funguria; Summary; References; Chapter 13: Pulmonary Disorders; Obstructive Lung Disease (Asthma and Chronic Obstructive Pulmonary Disease); Interstitial Lung Disease; Neuromuscular Disease; Post-ICU Care; Pulmonary Complications in Rehabilitation; Pneumonia; References; Chapter 14: Osteomyelitis; Classification; Diagnosis; Microbiology; Treatment; Summary; References; Chapter 15: Clostridium Difficile Colitis; Antibiotic-AssociatedDiarrhea Toxigenic Versus Nontoxigenic Clostridium Difficile |
| Record Nr. | UNINA-9910817416403321 |
| New York : , : demosMEDICAL, , 2015 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Neurocritical care monitoring / / editors, Chad M. Miller, Michel T. Torbey
| Neurocritical care monitoring / / editors, Chad M. Miller, Michel T. Torbey |
| Pubbl/distr/stampa | New York : , : demosMEDICAL, , 2015 |
| Descrizione fisica | 1 online resource (xii, 172 pages) : illustrations (some color) |
| Disciplina | 616.8/0428 |
| Soggetto topico |
Neurological intensive care
Central nervous system - Diseases - Diagnosis |
| Soggetto genere / forma | Electronic books. |
| ISBN | 1-61705-188-8 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cover; Title; Copyright; Contents; Contributors; Foreword; Preface; Share Neurocritical Care Monitoring; Chapter 1: Intracranial Pressure Monitoring; Introduction; Intracranial Pressure; Physiology of Intracranial Pressure Monitoring; Initiation of an Intracranial Pressure Monitoring Device; ICP Thresholds; Cerebral Perfusion Threshold; Intracranial Pressure Waveforms (Lundeberg Pathological Waves); Duration of Monitoring; Types of Intracranial Pressure Monitoring Devices; External Ventricular Drain EVD; Anatomy and Placement; Intraparenchymal Intracranial Pressure Monitor
Subarachnoid Intracranial Pressure MonitorEpidural Intracranial Pressure Monitors; Lumbar Catheter Intracranial Pressure Monitoring; Additional Concerns With Intracranial Pressure Monitoring Devices; Critical Care Management of Elevated Intracranial Pressure; General Measures; Specific Measures; References; Chapter 2: Transcranial Doppler Monitoring; Introduction; Subarachnoid Hemorrhage: Detection of Vasospasm; Technical Aspects of Transcranial Doppler; Middle Cerebral Artery Vasospasm; Anterior Cerebral Artery Vasospasm; Internal Carotid Artery Vasospasm Vertebral and Basilar Arteries VasospasmComplete TCD Examination with Lindegaard Ratio Determination; Distal Vasospasm Detection by TCD; Transcranial Doppler in Traumatic Brain Injury: Intracranial Pressure and Cerebral Perfusion Pressure; Brain Death; Acute Ischemic Stroke and Monitoring of Recanalization; Monitoring for Emboli; Carotid Endarterectomy and Carotid Artery Stenting; Summary; References; Chapter 3: Continuous EEG Monitoring; Introduction; EEG Techniques and Uses in the Intensive Care Unit; Quantitative EEG; Automated Seizure Detection Depth and Surface EEG Recording with Multimodality MonitoringEEG Applications; Subclinical Seizures and Status Epilepticus; Metabolic and Infectious Encephalopathies; Traumatic Brain Injury; Subarachnoid Hemorrhage; Detection of Vasospasm; Intracerebral Hemorrhage; Ischemic Stroke; Post-Cardiac Arrest; Postoperative Patients; References; Chapter 4: Cerebral Oxygenation; Introduction; Brain Tissue Oxygen Monitoring; Techniques; Placement; Interpretation and Clinical Utility; Effect of Hypoxia on Outcome; ICP-Guided Therapy Versus PbtO2-Guided Therapy Other Potential Clinical Applications for PbtO2 MonitoringTherapeutic Strategies; Jugular Bulb Oximetry; Near-Infrared Spectroscopy; References; Chapter 5: Brain Tissue Perfusion Monitoring; Introduction; Types of Monitors Available for Brain Tissue Perfusion Assessment; Literature Supporting Cerebral Perfusion Monitoring; Pathophysiology; Clinical Aspects of Monitoring Brain Tissue Perfusion; Which Patients Would Benefit From Monitoring?; Placement of Thermal Diffusion Monitors; What Are the Conventionally Accepted Monitoring Thresholds That Should Prompt Clinical Intervention?; Summary References |
| Record Nr. | UNINA-9910463374103321 |
| New York : , : demosMEDICAL, , 2015 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
